| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.5B | $6.1B | $5.6B | $5.0B | $4.7B | $1.1B | $1.1B | $1.2B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.2B | $3.9B | $3.4B | $3.0B | $2.6B | $0.5B | $0.6B | $0.6B |
| Net Income | $4.1B | $3.5B | $3.2B | $2.7B | $2.6B | $0.4B | $0.5B | $0.4B |
| EPS (Basic) | $11.18 | $9.69 | $8.87 | $7.41 | $7.30 | $1.18 | $1.31 | $1.10 |
| EPS (Diluted) | $11.16 | $9.67 | $8.86 | $7.40 | $7.29 | $1.18 | $1.31 | $1.09 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $198.4B | $137.4B | $129.7B | $174.2B | $196.8B | $124.7B | $75.2B | $77.5B |
| Current Assets | $165.4B | $103.0B | $94.9B | $139.1B | $161.8B | $89.3B | $39.6B | $41.9B |
| Cash & Equivalents | $4.4B | $2.9B | $2.9B | $2.7B | $2.8B | $1.6B | $1.6B | $1.4B |
| Total Liabilities | $169.7B | $111.0B | $103.0B | $147.3B | $169.4B | $98.3B | $49.1B | $51.5B |
| Current Liabilities | $160.3B | $102.3B | $93.4B | $137.7B | $160.4B | $88.2B | $38.5B | $41.3B |
| Stockholders' Equity | $28.7B | $26.5B | $26.7B | $26.9B | $27.4B | $26.3B | $26.1B | $25.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.3B | $3.7B | $3.5B | $3.1B | $2.4B | $2.7B | $2.7B | $2.4B |
| Investing Cash Flow | $1.5B | $-0.1B | $0.0B | $-0.5B | $0.1B | $-0.2B | $-0.2B | $-1.9B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $56.5B | $5.1B | $-48.3B | $-25.4B | $69.9B | $-2.5B | $-2.3B | $-1.1B |